
Orlirio Corrales, MD
Internal medicine, hospital care and clinical teaching. A clinical perspective on participant assessment and medical oversight.
English · SpanishYour protocol. Our people. Let’s talk.
A closer look at the people, spaces and conversations behind Integrated Health Research. Built for a thoughtful site evaluation.

Select a space to explore photographs from our actual center. Then come see it with your team.
Photography shows the center as documented. Equipment suitability, monitoring, access and space allocation are reviewed for each protocol.

Internal medicine, hospital care and clinical teaching. A clinical perspective on participant assessment and medical oversight.
English · Spanish
Family medicine and clinical trial operations. Experience spanning study startup, monitoring and closeout.
English · Spanish · French
MSN, Family Nurse Practitioner program. A bilingual clinical perspective, with prior medical and obstetrics/gynecology experience in Cuba and Ecuador.
English · SpanishProfiles are based on supplied CVs and credential documents. Current qualifications, training, availability and protocol-specific duties are reviewed separately.
A few details turn into a clear discussion brief. Explore what to review, then bring it to our team.
Take the overview with you. Review the published capabilities. Request the documentation your team needs.
Let’s explore your protocol, your requirements and the next step together.
Start with nonconfidential study requirements. Agree confidentiality terms with the team before sharing a confidential protocol. Our published scope is Phase II–IV outpatient research, without overnight stays. Enrollment, readiness and study approval require a specific assessment.
Send the phase, indication, proposed enrollment target, timeline and visit requirements through the sponsor form. The F06 feasibility worksheet helps review population estimates, staffing and resources before commitments. Phase II–IV only; do not attach patient information.
Discuss confidentiality requirements with the team before sharing a confidential protocol. Authorized sponsors can receive a private, expiring document-access code.
Coordinate a visit to review investigator availability, equipment suitability, operational records and protocol requirements. A requested visit is subject to confirmation.
The sponsor and site must resolve open requirements and confirm applicable approvals, agreements and protocol-specific readiness before study activities begin. Use the F08 checklist to record evidence, pending items and the responsible reviewer. These worksheets are drafts for review; they do not establish approved procedures or authorize activation. A web inquiry does not activate a study.
Investigator profile sources: CVs dated October 5, 2026 for Orlirio Corrales, M.D. (Principal Investigator) and Natalia Escuti, M.D. (Sub-Investigator). These are profile sources, not a current credential verification. Request signed CVs and up-to-date licenses and training records from the team. Investigator experience does not establish completed studies or performance at IHR.
View investigator profilesUse this checklist to request and verify evidence with the team. Listed documents are review requirements; listing them does not confirm that each has been uploaded or validated.
Phase II–IV, outpatient; no Phase I or overnight stays.
Review applicable authorization and protocol-specific approvals.
Investigator profiles and a private document center are available.
Request current signed CVs, licensure and training records.
Reported storage: −80°C and −40°C units; technical verification pending. The reported +20°C equipment or area still needs identification and intended-use confirmation.
Review inventory, actual settings, calibration, monitoring and contingency records.
To be reviewed during site qualification.
Request applicable SOPs, delegation, safety escalation, source documentation and data quality procedures.
No inspection outcome or site performance statistic is asserted here.
Request documented history when available; distinguish investigator experience from site results.